Biomet reports surging profits during its fiscal 2nd quarter, citing a nearly $70 million decrease in legal costs compared with the same period last year.
Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/13WmVSp
Cap comentari:
Publica un comentari a l'entrada